Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)
Close on Nov 18, 2026Market cap $24.59MP/E –Yield –
Rockwell Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Rockwell Medical's operating income for the twelve months ending Jun 30, 2026 was -$4.52M. For fiscal 2025 it was -$4.69M, down 871.5% from the year before. The highest annual figure on record is $608.00K in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.69M | -871.5% |
| FY2024 | Dec 31, 2024 | $608.00K | – |
| FY2023 | Dec 31, 2023 | -$6.67M | – |
| FY2022 | Dec 31, 2022 | -$16.78M | – |
| FY2021 | Dec 31, 2021 | -$30.34M | – |
| FY2020 | Dec 31, 2020 | -$28.42M | – |
| FY2019 | Dec 31, 2019 | -$34.53M | – |
| FY2018 | Dec 31, 2018 | -$32.44M | – |
| FY2017 | Dec 31, 2017 | -$25.92M | – |
| FY2016 | Dec 31, 2016 | -$20.21M | – |
| FY2015 | Dec 31, 2015 | -$15.10M | – |
| FY2014 | Dec 31, 2014 | -$17.56M | – |
| FY2013 | Dec 31, 2013 | -$47.06M | – |
| FY2012 | Dec 31, 2012 | -$54.26M | – |
| FY2011 | Dec 31, 2011 | -$21.68M | – |
| FY2010 | Dec 31, 2010 | -$2.87M | – |
| FY2009 | Dec 31, 2009 | -$5.48M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.06M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$398.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.58M | -181.8% |
| Q2 FY2025 | Jun 30, 2025 | -$1.35M | -361.9% |
| Q1 FY2025 | Mar 31, 2025 | -$1.36M | – |
| Q4 FY2024 | Dec 31, 2024 | -$519.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $1.94M | – |
| Q2 FY2024 | Jun 30, 2024 | $515.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.32M | – |
| Q4 FY2023 | Dec 31, 2023 | -$547.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.97M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.71M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.97M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.82M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.18M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.07M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.69M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.37M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.81M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.42M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.00M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.30M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.72M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.22M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.03M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.72M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.96M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.26M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.75M | – |
See a number that looks wrong?